ZLDPF:OTCMKTS
Zealand Pharma A/S
$35.93
arrow_upward
+1.21%(+0.43) 1D
Nov 16, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZLDPF...
Open
$35.40
High
$35.93
Low
$35.40
Mkt. cap
2.56B
Avg. vol.
449.00
Volume
280.00
52-wk high
$83.12
52-wk low
$33.08
Beta
1.25
Shares outstanding
71.61M
No. of employees
605
Open
$35.40
High
$35.93
Low
$35.40
Mkt. cap
2.56B
Avg. vol.
449.00
Volume
280.00
52-wk high
$83.12
52-wk low
$33.08
Beta
1.25
Shares outstanding
71.61M
No. of employees
605
News stories
From web sources and news partners
TradingView
·
2 hours ago
Stock Market: Will S&P 500 Open Up or Down Today?
The Motley Fool
·
17 hours ago
Is an Equal-Weight S&P 500 Fund Safer Right Now Than the One You Own?
ChartMill
·
14 hours ago
Today's S&P 500 Top Movers: Tyson Foods Leads Gainers, Lumentum Leads Decliners
Traders Union
·
9 hours ago
Michael A. Gayed: S&P 500 fell 19.35% and high yield dropped 5.9% in Q4 2018 selloff
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
About Zealand Pharma A/S
CEOAdam Steensberg
Employees605
FoundedApr 1, 1997
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitezealandpharma.com